Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial.
about
Update on bariatric surgical procedures and an introduction to the implantable weight loss device: the Maestro Rechargeable SystemMechanistic relationship between the vagal afferent pathway, central nervous system and peripheral organs in appetite regulationInterventional treatment of obesity and diabetes: An interim report on gastric electrical stimulationThe New Era of Drug Therapy for Obesity: The Evidence and the ExpectationsNeural control of energy balance: translating circuits to therapiesInnovative solutions in bariatric surgeryGut-Brain Cross-Talk in Metabolic Control.Tissue damage thresholds during therapeutic electrical stimulationNeurostimulation of the gastrointestinal tract: review of recent developments.Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge TrialGastrointestinal traits: individualizing therapy for obesity with drugs and devicesGastric electrical stimulation treatment of type 2 diabetes: effects of implantation versus meal-mediated stimulation. A randomized blinded cross-over trial.Post-implant Analysis of Epidemiologic and Eating Behavior Data Related to Weight Loss Effectiveness in Obese Patients Treated with Gastric Electrical Stimulation.Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study.Universal equation for estimating ideal body weight and body weight at any BMITreatment of Obesity: Weight Loss and Bariatric Surgery.Eating disinhibition and vagal tone moderate the postprandial response to glycemic load: a randomised controlled trial.Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial.Vagal afferent activation decreases brown adipose tissue (BAT) sympathetic nerve activity and BAT thermogenesis.Latest approaches for the treatment of obesity.Diarrhea after bariatric procedures: Diagnosis and therapy.Brain stimulation in obesity.Role of the vagus nerve in the development and treatment of diet-induced obesity.Recent Trends in Endoscopic Management of Obesity.Endoscopic Devices for Obesity.Extra-cardiac stimulators: what do cardiologists need to know?Impact of the feedback provided by a gastric electrical stimulation system on eating behavior and physical activity levels.Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.Bariatric endoscopy: current state of the art, emerging technologies, and challenges.Medical devices for the treatment of obesity.Bariatric Surgery and Long-term Durability of Weight Loss.Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study.Long-Term Follow-Up of Autonomic and Enteric Measures in Patients Undergoing Vertical Banded Gastroplasty for Morbid ObesityDesensitization of stimulation-induced weight loss: A secondary finding in a patient with vagal nerve stimulator for drug-resistant epilepsy.The Role of the Autonomic Nervous System in the Pathophysiology of Obesity.Selective inhibition of small-diameter axons using infrared light.Effects of sleeve gastrectomy plus trunk vagotomy compared with sleeve gastrectomy on glucose metabolism in diabetic rats.Obesity in Women: Insights for the Clinician.Cardiovascular autonomic effects of vagus nerve stimulation.Modeling the response of small myelinated axons in a compound nerve to kilohertz frequency signals.
P2860
Q26738342-A6178B7E-5829-424B-9CC8-60AB3A822898Q26749523-4DA822AF-CB0E-4779-9998-6F23EDE70138Q26750871-8553EA43-5794-4636-8BAD-A0E21834F121Q26827555-3D46F4C8-A8DB-4A59-8CA2-4633403E14EAQ27005992-F52CF2AE-536E-41AE-AFFA-FF5F71D48622Q28068021-FA1A7291-1438-4FE3-9F20-731EC5C1F899Q30235568-7D715029-4412-4139-BF0C-504E306340E1Q34510131-76DE6B8E-619E-4028-B74C-94A9A3E7FE6BQ35251850-5F969EDC-F09A-4F0D-94C6-81A30D028199Q35889773-17A09E3C-2FC9-4991-9055-3FBABBC0AB9AQ35994552-82D765F2-DFF1-44E7-8EDF-FD3867C1CCE8Q36004370-FB2916E6-E66E-4CD5-A1E2-53D8D09E042EQ36232930-D9328E85-109C-44A0-BF5D-870BE205C1B5Q36798945-41C44420-B353-4542-B36A-573E3BD8EFE8Q36827971-6B53EB15-2567-447B-BDD6-15A70EC24872Q36956145-B48570C0-18E8-4D0D-8B55-5E34B36CAB42Q37352539-81F73434-A845-4894-99F9-A0552B340987Q37533051-9E5BBFD8-22A3-4E29-BBE7-853973BD69A0Q37708217-E423062F-2CF6-4A17-A6B0-C8E5200048F0Q38475978-FEA7FFC8-0431-40EC-A5B7-AB4938697929Q38648297-86F578D9-327C-4335-96FF-B1837E5C0B0EQ38701488-7FC5A839-E004-44B3-8F64-F8B99AE98A41Q38766761-0D212168-B6B0-4A0E-8270-F7456B165823Q38806795-A23919B1-54ED-440E-B0EE-2C4E4426B126Q38817948-6667661C-8D03-46E7-8F2B-627411C9D33EQ38846536-2B5A503F-FED8-42EE-8018-40E566B27E9CQ38977458-EBDC4C19-3C84-4F58-BAC7-713473AA7BAEQ39047697-CF71998C-A234-4F92-9A74-D772E5DA951AQ39084177-3ED4E394-6683-4247-8DAF-50606E7CAFCBQ39429642-C04C09D6-6263-4B86-892A-8192C8672444Q39436582-1A3EF904-4971-47DE-BDE5-2059E7C2244FQ40426709-7CAF7CB6-EB7B-4CBD-95F6-A135143A7BA9Q41353321-E6181DE4-5BDA-4437-9360-9D3BF59F0F91Q41566545-D2FD2FC4-5ADF-4854-ACF1-1D8BFEAAB4F1Q41665400-4BDC5D23-B0F7-4A48-B26D-7D7042153692Q42206981-FB270A9B-41CF-452E-BB55-A9F988D82582Q42261841-8771119E-6D61-4A10-8949-B661B567B889Q46301919-79C73A7A-721F-4D4C-AA74-A715388C8793Q47409265-FBB9BAB1-572A-48CC-BB9A-944265E39D83Q47908918-C9819CC3-8184-45FA-A71A-6877255335B5
P2860
Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Effect of reversible intermitt ...... rge randomized clinical trial.
@en
type
label
Effect of reversible intermitt ...... rge randomized clinical trial.
@en
prefLabel
Effect of reversible intermitt ...... rge randomized clinical trial.
@en
P2093
P356
P1476
Effect of reversible intermitt ...... rge randomized clinical trial.
@en
P2093
Anthony Brancatisano
Bruce M Wolfe
Charles J Billington
Christopher J Miller
Clifford Deveney
Daniel B Leslie
Florencia G Que
James Swain
James Toouli
James W Maher
P304
P356
10.1001/JAMA.2014.10540
P407
P577
2014-09-01T00:00:00Z